Giessen, Germany

Robert Voswinckel

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Geissen, DE (2019)
  • Wettenberg, DE (2016 - 2020)
  • Giessen, DE (2013 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Robert Voswinckel

Introduction

Robert Voswinckel is a notable inventor based in Giessen, Germany. He has made significant contributions to the field of pulmonary medicine, holding a total of 9 patents. His work focuses on improving the administration of medications for patients suffering from pulmonary diseases.

Latest Patents

Among his latest patents is the method for Treprostinil administration by inhalation. This innovation allows Treprostinil to be administered using a metered dose inhaler, providing patients with greater autonomy in their treatment. Additionally, he has developed methods for the administration of iloprost as an aerosol bolus. This invention relates to novel methods and compositions for treating pulmonary diseases, particularly pulmonary arterial hypertension. The aerosolisable compositions of iloprost are designed for inhalation therapy, ensuring that the administration is patient-friendly, effective, and well tolerated.

Career Highlights

Throughout his career, Voswinckel has worked with prominent companies in the pharmaceutical industry, including United Therapeutics Corporation and Vectura GmbH. His experience in these organizations has contributed to his expertise in developing innovative treatment methods for pulmonary conditions.

Collaborations

Robert Voswinckel has collaborated with notable professionals in his field, including Thomas Schmehl and Werner Seeger. These collaborations have further enhanced his research and development efforts.

Conclusion

Robert Voswinckel's contributions to pulmonary medicine through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the treatment of pulmonary diseases, making a significant impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…